Autres langues

27/05 Shivalik Rasayan Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026
27/05 Shivalik Rasayan Limited Announces Resignation of Sanjay Bansal as Non-Executive Director, Effective May 27, 2026
27/05 Shivalik Rasayan Limited Recommends Final Dividend for the Financial Year 2025-26
27/05 Shivalik Rasayan Ltd March-quarter consol net profit 45.3 million rupees
13/02 Shivalik Rasayan Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025
14/11 Shivalik Rasayan Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025
29/09/25 Shivalik Rasayan Limited Approves the Re-Designation of Mr. Ashwani Kumar Sharma as a Non-Executive, Non-Independent Director
12/08/25 Shivalik Rasayan Limited Reports Earnings Results for the First Quarter Ended June 30, 2025
30/05/25 Shivalik Rasayan Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025
30/05/25 Shivalik Rasayan Limited announces Annual dividend, payable on October 27, 2025
24/04/25 Medicamen Biotech Limited announced that it has received INR 535.6816 million in funding from Kim Ginnerup ApS, Shivalik Rasayan Limited, VERALOGIX HOLDINGS LTD and other investors
26/02/25 Medicamen Biotech Limited announced that it expects to receive INR 775.7875 million in funding from Kim Ginnerup ApS, Shivalik Rasayan Limited, VERALOGIX HOLDINGS LTD
04/10/24 Shivalik Rasayan Gets US FDA Nod for Pharmaceutical Ingredient Facility in Gujarat; Shares Rise 3%
30/09/24 Shivalik Rasayan Limited Announces Board Appointments
13/08/24 Shivalik Rasayan Limited Reports Earnings Results for the First Quarter Ended June 30, 2024
13/08/24 Shivalik Rasayan Limited Announces Term Expiry of Harish Pande, Arun Kumar and Kailash Gupta as Independent Directors
29/05/24 Shivalik Rasayan Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
29/05/24 Shivalik Rasayan Limited Recommends Final Dividend for the Financial Year 2023-2024, Payable on or Before October 27, 2024
10/04/24 Shivalik Rasayan Gets Seven Observations from US FDA for Baruch, India Facility
09/04/24 Shivalik Rasayan Limited Announces Completion of US FDA Inspection At the API Facility of Shivalik Rasayan Limited At Dahej Facility
07/03/24 Shivalik Rasayan Limited Receives Licenses to Start Manufacturing at Newly Build Agro-Chemical Plant
12/02/24 Shivalik Rasayan Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
10/11/23 Shivalik Rasayan Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
29/09/23 Shivalik Rasayan Limited Declares Final Dividend on Equity Shares for the Financial Year 2022-23
18/09/23 Shivalik Rasayan Limited Announces Resignation of Akshay Kant Chaturvedi as Executive Director
Aucun résultat pour cette recherche